Bell Investment Advisors’s Global Blood Therapeutics, Inc. GBT Stock Holding History

Bell Investment Advisors’s Portfolio GBT Stock Details GBT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-7	Closed	–	–	2074
2022 Q3	$0	Buy	+7	New	+$386	﹤0.01%	2037
2021 Q4	$1K	Sell	18 -17	-49%	-$527	﹤0.01%	1723
2021 Q3	$1K	Buy	+35	New	+$1.03K	﹤0.01%	1675

Other funds holding GBT

BTI

Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Bell Investment Advisors's GBT Position: Q4 2022 in Review

Bell Investment Advisors sold out of Global Blood Therapeutics, Inc. (GBT) in Q4 2022, closing a stake of 7 shares.

Bell Investment Advisors first reported a position in GBT in Q3 2021 and held it in 3 quarters. The position peaked at $1K in Q4 2021. 2 funds tracked by Wall St. Rank hold GBT as of Q4 2022.

Bell Investment Advisors reported no remaining Global Blood Therapeutics, Inc. position as of Q4 2022 after selling out during the quarter.
Bell Investment Advisors sold 7 Global Blood Therapeutics, Inc. shares in Q4 2022.
Bell Investment Advisors first reported a position in Global Blood Therapeutics, Inc. in Q3 2021 and held it in 3 quarters.
Bell Investment Advisors's Global Blood Therapeutics, Inc. position peaked at $1K in Q4 2021.
2 funds tracked by Wall St. Rank held Global Blood Therapeutics, Inc. as of Q4 2022.

Based on Bell Investment Advisors's 13F filing for Q4 2022, filed 9 Feb 2023.